General


Peptide: SMAP-29
Microorganism:Staphylococcus aureus
Administration:
Stage: Formation (3-24h)
Notes:Sa4 clinical isolate

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Crystal violet assay Not Active 0.626 uM

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or giuseppe.maccari@iit.it